
Introduction: Chagas Disease (CD) is an infectious illness caused by the protozoan Trypanosoma cruzi. Despite being endemic in tropical countries, establishing a fully effective treatment remains a challenge due to the limited therapeutic arsenal and the complexity of parasite persistence during the chronic phase. Aim: The present study aimed to conduct a literature review regarding the current approach and future perspectives of the pharmacological treatment of CD. Methodology: This is a narrative review based on articles from the PubMed, SciELO, and LILACS databases. Relevant articles focusing on the mechanisms of action, drug repurposing, and novel therapeutic targets were critically analyzed to compose the results. Results: Standard drugs, benznidazole and nifurtimox, show notable efficacy primarily in the acute phase, while substances such as posaconazole, TAK-187, and ravuconazole demonstrate promising performance in preclinical studies. The review highlights innovative approaches, such as drug repurposing (Flucofuron) and the identification of new targets focused on the collapse of redox homeostasis and mitochondrial dysfunction (apoptosis-like). It was evidenced that the combination of active principles, such as benznidazole associated with the novel compound 1k in 3D cardiac microtissue models, is effective in controlling infection with reduced toxicity. Although challenges persist regarding accessibility and diagnosis, advances in understanding the parasite's cell death mechanisms represent a crucial step. Conclusions: In this context, collaborative work between researchers and governments remains essential to ensure that these new therapeutic candidates advance to clinical practice, improving the quality of life for patients.
Introduction: Plant extracts are widely investigated as sources of cytostatic bioactive compounds. Previous studies have reported cytotoxic activity of several Lamium species in vitro. However, comparative data across species and cell lines remain scarce, and the role of phenolic compounds in this activity is still poorly understood. Objective: Hydroalcoholic extracts of L. album, L. purpureum, L. maculatum, and L. galeobdolon were tested against A549 (lung adenocarcinoma), BJ-hTERT (immortalized human foreskin fibroblasts), HeLa (human cervical carcinoma), HROG04 (human glioblastoma), MeWo (human melanoma), NIH:OVCAR-3 (human ovarian adenocarcinoma), PC-3 (prostate adenocarcinoma), ZR-75 (human breast adenocarcinoma) cell lines. Methodology: Cytotoxic activity was evaluated using the MTT assay, and changes in phenolic composition were analyzed by HPLC-DAD. Results: all investigated extracts exhibited the lowest IC₅₀ values against NIH:OVCAR-3, HROG04, and ZR-75 cells (<375 µg/mL), with a selectivity index relative to BJ-hTERT cells exceeding 4 for all extracts. HPLC-DAD revealed changes in extracellular phenolic concentrations, including the appearance of new peaks and the disappearance of others. BJ-hTERT cells showed less marked alterations in the medium composition. Conclusion: Lamium spp. extracts exhibit selective cytotoxicity toward specific cancer cell lines, possibly associated with dynamic changes in extracellular phenolic compounds.
Introduction: Isotretinoin (ITN), a vitamin A derivative commonly used for acne treatment, is limited by safety concerns related to its adverse effects. Protein-based delivery systems represent a promising strategy to improve its therapeutic profile. Collagen (COL), the most abundant mammalian protein, is an attractive biomaterial for drug delivery applications. Aim: This study investigated, using an in silico approach, the interaction between ITN and different human COL types (I, II and III) to evaluate their potential as drug-protein complexes for ITN delivery. Methods: Molecular docking between ITN and COL was performed at two pH values (4.0 and 7.0). Subsequently, 200 ns molecular dynamics (MD) simulations were carried out at each pH for every complex, and binding free energies were estimated using the MM-GBSA method. Results: Molecular docking showed that ITN exhibited the highest affinity for COL I at pH 4.0, followed by COL III, whereas the weakest interaction was observed with COL II. MD simulations suggested that the protonation state of ITN influences complex formation, supporting greater stability at pH 4.0, when ITN is in its non-ionized form. The trajectories also showed multiple potential binding sites within COL, suggesting the possibility of stoichiometries other than 1:1. MM-GBSA calculations revealed the energetic contributions stabilizing the ITN-COL complexes, with the strongest interaction for COL I at pH 4.0. Conclusions: These results suggest that COL I at pH 4.0 is a promising carrier candidate for ITN delivery, with potential applications in the development of safer anti-acne therapeutic strategies.
Introducción: El uso creciente de fármacos ha derivado en la acumulación y disposición inadecuada de medicamentos caducos en el hogar, convirtiéndose en una fuente de contaminantes emergentes. En regiones con alta vulnerabilidad hidrológica como Villahermosa, Tabasco, esta problemática se intensifica debido a la facilidad de dispersión de sustancias hacia los cuerpos de agua. El objetivo de este estudio fue evaluar las prácticas de almacenamiento y disposición de medicamentos caducos en hogares de Villahermosa e identificar sus riesgos ambientales y sanitarios. Metodología: Se realizó un estudio observacional, descriptivo y transversal. Se aplicó un cuestionario estructurado de 16 preguntas a una muestra de 150 participantes mediante muestreo no probabilístico por bola de nieve. Los datos se procesaron mediante estadística descriptiva en Microsoft Excel (versión 2606). Resultados: Los medicamentos predominantes en los botiquines domésticos fueron analgésicos (38,0 %) y antipiréticos (22,3 %). Aunque el 95 % de los encuestados verifica la fecha de caducidad antes del consumo, el 69 % desecha los fármacos caducos en la basura doméstica y el 9 % a través del drenaje. Asimismo, el 76 % de los participantes manifestó no estar consciente de los impactos ambientales derivados de estas prácticas. Conclusiones: Existe una tendencia generalizada a la acumulación de fármacos y al uso de métodos de eliminación inadecuados que favorecen la liberación de residuos farmacológicamente activos al entorno. Los resultados evidencian una brecha significativa en el conocimiento de la ecofarmacovigilancia, subrayando la necesidad urgente de fortalecer la educación sanitaria y los programas de recolección segura como SINGREM para mitigar riesgos ambientales en la región.
Objective: To evaluate the hypoglycemic effect of myrtenol-solid lipid nanoparticles (Myrtenol-SLN) in dexamethasone-induced hyperglycemic rats. Methods: Thirty adult male Wistar rats were divided into five groups: normal control, normal treated with Myrtenol-SLN, hyperglycemic control, metformin-treated, and Myrtenol-SLN-treated groups. Hyperglycemia was induced by intraperitoneal dexamethasone (1 mg/kg) for 8 days. Treatments were administered orally for 10 days. Blood glucose levels were measured daily using a glucometer. Results: Myrtenol-SLN treatment significantly reduced blood glucose levels by day 5 and showed a highly significant reduction by day 10 compared with baseline values. The hypoglycemic effect of Myrtenol-SLN was comparable to metformin, with no significant differences observed between the two treatment groups during the study period. No adverse effects were detected throughout the experiment. Conclusions: Myrtenol-SLN demonstrated a significant hypoglycemic effect in dexamethasone-induced hyperglycemic rats and may represent a promising natural therapeutic approach for hyperglycemia management.